BETA

The mitochondria transfer field has gained a tremendous amount of momentum in recent years and captured the imaginations of many scientists. The rapid pace of research has led to the use of many different terms to describe similar processes, creating confusion among researchers. This review article was led by Dr. Jonathan R. Brestoff, MD, PhD, MPH at Washington University in St. Louis School of Medicine and is the product of 32 leading investigators from around the world to establish recommendations and guidance on terminology to describe mitochondria transfer and therapeutic administration of mitochondria. The review was constructed in two working groups that were organized by time zones, where nomenclature frameworks were proposed and disagreements were debated. The article’s outline was generated through consensus and used to draft this pre-print version of the article.

We are now inviting your insights, comments, questions, and feedback to help improve upon this article. This public commenting period will last for 30 days. After this period, we will review all comments and address them in a revised version of the manuscript, which will then be submitted for peer review at an independent academic journal. Please note that while commenting on this article does not imply or entitle co-authorship, your comments and our responses will be included in the supplementary information, with attribution to you.

Thank you for taking the time to read this article and providing your feedback. It is sincerely appreciated.

Download a PDF of the article here.

Please submit your comments in the form below.